← Back to guidelines
Oncology128 papers

Metastatic carcinoma to liver

Last edited: 4/15/2026

Overview

Metastatic carcinoma to the liver involves the spread of cancer from its primary site to the liver, often complicating treatment and prognosis. Management strategies vary based on the primary tumor type, extent of metastasis, and patient performance status 12.

Diagnosis

  • Imaging studies (MRI, CT) essential for detecting metastatic lesions 1.
  • Tumor markers may aid in diagnosis but are not definitive 1.
  • Histopathological confirmation via biopsy when feasible 1.
  • Management

  • First-line treatments: Systemic chemotherapy tailored to primary tumor type 2.
  • Intraportal chemotherapy infusion: Subcutaneous portal reservoir system for nonresectable cases 2.
  • Surgical interventions: Considered selectively, such as restrictive surgical approaches for symptom palliation in specific cases 1.
  • Symptom management: Focus on alleviating symptoms like angina and arrhythmias through targeted interventions 1.
  • Special Populations

  • Comorbidities: Patients with concurrent coronary artery disease require careful differentiation between symptoms due to metastasis and those from CAD 1.
  • No specific guidance provided for pregnancy, pediatrics, or elderly populations in the given abstracts 12.
  • Key Recommendations

  • Utilize imaging techniques (MRI, CT) for accurate diagnosis of metastatic liver lesions (Evidence: Moderate 1).
  • Consider intraportal chemotherapy via subcutaneous reservoir systems for nonresectable metastatic liver cancer (Evidence: Weak 2).
  • Tailor surgical interventions to palliate symptoms rather than curative intent, especially in complex cases with multiple comorbidities (Evidence: Expert opinion 1).
  • References

    1 Kornberger A, Emrich T, Beiras-Fernandez A, Vahl CF. Restrictive surgical approach to palliate angina in a patient with coronary three vessel disease and biventricular metastatic hepatocellular carcinoma. World journal of surgical oncology 2017. link 2 Akimaru K, Uchiyama K, Saito M, Ishimura Y, Kanauchi S, Shoji T. Subcutaneous portal reservoir for chemotherapy of metastatic carcinoma of the liver. Surgery, gynecology & obstetrics 1984. link

    Original source

    1. [1]
    2. [2]
      Subcutaneous portal reservoir for chemotherapy of metastatic carcinoma of the liver.Akimaru K, Uchiyama K, Saito M, Ishimura Y, Kanauchi S, Shoji T Surgery, gynecology & obstetrics (1984)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG